Form 4: Penny Ann Wheeler Reports Stock Option Grant in National Research Corp Filing

Sentiment:

SEC Form 4 Filing


Penny Ann Wheeler, a director of National Research Corporation, reports the acquisition of stock options in a recent SEC filing.

Summary

  • Penny Ann Wheeler, a director at National Research Corporation (NRC), filed a Form 4 with the SEC.
  • The filing reports the grant of stock options to Wheeler on May 7, 2025, under the Issuer's 2025 Omnibus Incentive Plan.
  • Wheeler received options to purchase 34,917 shares of common stock at an exercise price of $13.09 per share.
  • The options vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.
  • The options expire on May 7, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, indicating confidence in the company's future performance.

Positives

  • The grant of stock options aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting and expiration of the stock options.

Industry Context

This filing is a routine disclosure related to executive compensation and is common among publicly traded companies. It reflects standard practices for incentivizing directors and aligning their interests with shareholders.

Comparison to Industry Standards

  • Stock option grants are a common form of executive compensation in publicly traded companies.
  • The vesting schedule and exercise price are typical components of such grants, designed to incentivize long-term performance.
  • Companies like Medpace Holdings, Inc. and Syneos Health also utilize stock options as part of their compensation packages for directors and executives.

Stakeholder Impact

  • Shareholders may view the stock option grant as a positive incentive for the director to contribute to the company's long-term success.
  • Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/07/2025Date of the stock option grant and the Issuer's 2025 annual shareholder meeting.
05/09/2025Date of the signature on the Form 4 filing.
05/07/2035Expiration date of the stock options.

Keywords

Form 4, Stock Options, National Research Corporation, Director, Penny Ann Wheeler, SEC Filing, NRC, Omnibus Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.